{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T02:37:32Z","timestamp":1648694252734},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.jacl.2010.08.024","type":"journal-article","created":{"date-parts":[[2010,9,13]],"date-time":"2010-09-13T10:55:06Z","timestamp":1284375306000},"page":"501-507","source":"Crossref","is-referenced-by-count":3,"title":["An evaluation of alanine transaminase and creatine kinase elevations with the use of ezetimibe in an ambulatory care setting"],"prefix":"10.1016","volume":"4","author":[{"given":"Brandy","family":"McGinnis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Schimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kara","family":"Hutka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2010.08.024_bib1","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2010.08.024_bib2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"NCEP Report: Implication of the Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2010.08.024_bib3","unstructured":"Zetia\u00ae (ezetimibe) product information. Merck\/Shering-Plough Pharmaceuticals. North Wales, PA. Issued July 2009. Available at: http:\/\/www.msppharma.com\/msppharma\/documents\/zetia_pi.pdf. Accessed May 5, 2010."},{"key":"10.1016\/j.jacl.2010.08.024_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ecl.2008.11.007","article-title":"Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety","volume":"38","author":"Hou","year":"2009","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.jacl.2010.08.024_bib5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1742-1241.2007.01592.x","article-title":"Ezetimibe-associated adverse effects: what the clinician needs to know","volume":"62","author":"Florentin","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jacl.2010.08.024_bib6","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jacl.2008.08.430","article-title":"Ezetimibe-related myopathy: a systemic review","volume":"2","author":"Slim","year":"2008","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2010.08.024_bib7","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0002-9149(02)02356-1","article-title":"Side effects of statins: hepatitis versus \u201ctransaminitis\u201d-myositis verses \u201cCPKitis\u201d","volume":"89","author":"Dujovne","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2010.08.024_bib8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0168-8278(90)90124-A","article-title":"Criteria of drug-induced liver disorders. Report of an international consensus meeting","volume":"11","author":"Benichou","year":"1990","journal-title":"J Hepatol"},{"key":"10.1016\/j.jacl.2010.08.024_bib9","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMra052270","article-title":"Drug-related hepatotoxicity","volume":"354","author":"Navarro","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2010.08.024_bib10","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1345\/aph.1G035","article-title":"Differential association between statin exposure and elevated levels of creatine kinase","volume":"39","author":"Chan","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jacl.2010.08.024_bib11","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1368-5031.2005.00565.x","article-title":"Efficacy and safety of ezetimibe co-administered with ongoing atorvastatin therapy in achieving low-density lipoprotein goal in patients with hypercholesterolemia and coronary heart disease","volume":"59","author":"Cruz-Fernandez","year":"2005","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jacl.2010.08.024_bib12","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0002-9149(02)02774-1","article-title":"Efficacy and safety of ezetimibe added to ongoing statin therapy for\u00a0treatment of patients with primary hypercholesterolemia","volume":"90","author":"Gagne","year":"2002","journal-title":"Am J\u00a0Cardiol"},{"key":"10.1016\/j.jacl.2010.08.024_bib13","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1161\/01.CIR.0000068312.21969.C8","article-title":"Effect of ezetimibe co-administered with atorvastatin in 628 patients with primary hypercholesterolemia","volume":"107","author":"Ballantyne","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2010.08.024_bib14","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0002-9149(02)03236-8","article-title":"Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia","volume":"91","author":"Kerzner","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2010.08.024_bib15","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0735-1097(02)02610-4","article-title":"Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia","volume":"40","author":"Davidson","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2010.08.024_bib16","doi-asserted-by":"crossref","first-page":"620","DOI":"10.4065\/79.5.620","article-title":"Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled trial","volume":"79","author":"Goldberg","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacl.2010.08.024_bib17","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.amjcard.2004.02.059","article-title":"Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain national cholesterol education program adult treatment panel III low-density lipoprotein cholesterol goals","volume":"93","author":"Feldman","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2010.08.024_bib18","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.amjcard.2004.02.060","article-title":"Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia","volume":"93","author":"Ballantyne","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2010.08.024_bib19","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJMoa0800742","article-title":"Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia","volume":"325","author":"Kastelein","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2010.08.024_bib20","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.cgh.2006.04.014","article-title":"Severe hepatic side effects of ezetimibe","volume":"4","author":"Stolk","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jacl.2010.08.024_bib21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1258\/0004563054890105","article-title":"Drug-induced acute autoimmune hepatitis during combination therapy with atorvastatin and ezetimibe","volume":"42","author":"van Heyningen","year":"2005","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.jacl.2010.08.024_bib22","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1592\/phco.28.9.1188","article-title":"Simvastatin-ezetimibe-induced hepatic failure necessitating liver transplantation","volume":"28","author":"Tuteja","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jacl.2010.08.024_bib23","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/MEG.0b013e3282f1752d","article-title":"Severe jaundice following treatment with ezetimibe","volume":"20","author":"Ritchie","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jacl.2010.08.024_bib24","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s10620-006-9497-2","article-title":"Drug-induced liver injury associated with ezetimibe therapy","volume":"52","author":"Lie","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jacl.2010.08.024_bib25","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S1262-3636(07)70292-6","article-title":"Elevation of CKP induced by ezetimibe monotherapy: report on two cases","volume":"32","author":"Meas","year":"2006","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jacl.2010.08.024_bib26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1592\/phco.27.2.309","article-title":"Myopathy associated with atorvasatin-ezetmibe combination therapy","volume":"27","author":"Weffald","year":"2007","journal-title":"Pharmacotherapy"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328741000320X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328741000320X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T03:55:25Z","timestamp":1544241325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193328741000320X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S193328741000320X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2010.08.024","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}